Cargando…

miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma

An increasing number of microRNAs have been found to be involved in tumorigenesis, including melanoma tumorigenesis. miR-204-5p is down-regulated and functions as a tumor suppressor in many human malignant tumors. miR-204-5p expression is also decreased in melanoma tissues, but its biological roles...

Descripción completa

Detalles Bibliográficos
Autores principales: Luan, Wenkang, Qian, Yao, Ni, Xin, Bu, Xuefeng, Xia, Yun, Wang, Jinlong, Ruan, Hongru, Ma, Shaojun, Xu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338948/
https://www.ncbi.nlm.nih.gov/pubmed/28280358
http://dx.doi.org/10.2147/OTT.S128819
_version_ 1782512589909000192
author Luan, Wenkang
Qian, Yao
Ni, Xin
Bu, Xuefeng
Xia, Yun
Wang, Jinlong
Ruan, Hongru
Ma, Shaojun
Xu, Bin
author_facet Luan, Wenkang
Qian, Yao
Ni, Xin
Bu, Xuefeng
Xia, Yun
Wang, Jinlong
Ruan, Hongru
Ma, Shaojun
Xu, Bin
author_sort Luan, Wenkang
collection PubMed
description An increasing number of microRNAs have been found to be involved in tumorigenesis, including melanoma tumorigenesis. miR-204-5p is down-regulated and functions as a tumor suppressor in many human malignant tumors. miR-204-5p expression is also decreased in melanoma tissues, but its biological roles and molecular mechanisms in malignant melanoma remain unclear. In this study, the aberrant down-regulation of miR-204-5p was detected in melanoma, especially in metastatic melanoma. miR-204-5p also served as a protective factor for the prognosis of melanoma patients. We determined that miR-204-5p suppresses cell proliferation, migration and invasion, and promotes cell apoptosis in melanoma. Matrix metalloproteinases-9 and B-cell lymphoma-2 are the functional targets of miR-204-5p, through which it plays an important biological role in malignant melanoma. The effect of miR-204-5p on malignant melanoma is verified using a xenograft model. We also determined that miR-204-5p increases 5-fluorouracil and cisplatin (DDP) chemosensitivity in malignant melanoma cells. This finding elucidates new functions and mechanisms for miR-204-5p in melanoma development, and provides potential therapeutic targets for the treatment of melanoma.
format Online
Article
Text
id pubmed-5338948
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-53389482017-03-09 miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma Luan, Wenkang Qian, Yao Ni, Xin Bu, Xuefeng Xia, Yun Wang, Jinlong Ruan, Hongru Ma, Shaojun Xu, Bin Onco Targets Ther Original Research An increasing number of microRNAs have been found to be involved in tumorigenesis, including melanoma tumorigenesis. miR-204-5p is down-regulated and functions as a tumor suppressor in many human malignant tumors. miR-204-5p expression is also decreased in melanoma tissues, but its biological roles and molecular mechanisms in malignant melanoma remain unclear. In this study, the aberrant down-regulation of miR-204-5p was detected in melanoma, especially in metastatic melanoma. miR-204-5p also served as a protective factor for the prognosis of melanoma patients. We determined that miR-204-5p suppresses cell proliferation, migration and invasion, and promotes cell apoptosis in melanoma. Matrix metalloproteinases-9 and B-cell lymphoma-2 are the functional targets of miR-204-5p, through which it plays an important biological role in malignant melanoma. The effect of miR-204-5p on malignant melanoma is verified using a xenograft model. We also determined that miR-204-5p increases 5-fluorouracil and cisplatin (DDP) chemosensitivity in malignant melanoma cells. This finding elucidates new functions and mechanisms for miR-204-5p in melanoma development, and provides potential therapeutic targets for the treatment of melanoma. Dove Medical Press 2017-02-27 /pmc/articles/PMC5338948/ /pubmed/28280358 http://dx.doi.org/10.2147/OTT.S128819 Text en © 2017 Luan et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Luan, Wenkang
Qian, Yao
Ni, Xin
Bu, Xuefeng
Xia, Yun
Wang, Jinlong
Ruan, Hongru
Ma, Shaojun
Xu, Bin
miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
title miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
title_full miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
title_fullStr miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
title_full_unstemmed miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
title_short miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
title_sort mir-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and b-cell lymphoma-2 in malignant melanoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338948/
https://www.ncbi.nlm.nih.gov/pubmed/28280358
http://dx.doi.org/10.2147/OTT.S128819
work_keys_str_mv AT luanwenkang mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma
AT qianyao mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma
AT nixin mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma
AT buxuefeng mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma
AT xiayun mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma
AT wangjinlong mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma
AT ruanhongru mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma
AT mashaojun mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma
AT xubin mir2045pactsasatumorsuppressorbytargetingmatrixmetalloproteinases9andbcelllymphoma2inmalignantmelanoma